Suchergebnisse - "Zenz, Thorsten"

PubPharm (12)

1

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK) : final results of a multicentre, phase 3, open-label, randomised trial

enthalten in: The Lancet. Haematology | 2023

von Chamuleau, M. | Stenner, F. | Chitu, D. | +28

2

Genetics of "high-risk" chronic lymphocytic leukemia in the times of chemoimmunotherapy

enthalten in: Haematologica | 2020

von Ring, A. | Zenz, T.

CommentOn: Haematologica. 2020 May;105(5):1379-1390. - PMID 31467127

3

HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies

enthalten in: Blood | 2017

von Bobrowicz, M. | Dwojak, M. | Pyrzynska, B. | +30

4

TP53 mutation and survival in aggressive B cell lymphoma

enthalten in: International journal of cancer | 2017

von Zenz, T. | Kreuz, M. | Fuge, M. | +19

5

BRAF inhibition in hairy cell leukemia with low-dose vemurafenib

enthalten in: Blood | 2016

von Dietrich, S. | Pircher, A. | Endris, V. | +25

CommentIn: Blood. 2016 Jun 9;127(23 ):2784-5. - PMID 27282942

6

Gene mutations and treatment outcome in chronic lymphocytic leukemia : results from the CLL8 trial

enthalten in: Blood | 2014

von Stilgenbauer, S. | Schnaiter, A. | Paschka, P. | +29

CommentIn: Blood. 2014 May 22;123(21):3212-4. - PMID 24855188

7

Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies

enthalten in: mAbs | 2014

von Winiarska, M. | Bojarczuk, K. | Pyrzynska, B. | +21

8

Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2013

von Dietrich, S. | Hüllein, J. | Hundemer, M. | +15

9

Risk categories and refractory CLL in the era of chemoimmunotherapy

enthalten in: Blood | 2012

von Zenz, T. | Gribben, J. | Hallek, M. | +3

10

Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia : a multivariate analysis from the randomized GCLLSG CLL8 trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Böttcher, S. | Ritgen, M. | Fischer, K. | +13